These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 22963567)

  • 1. The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.
    Lescaudron L; Naveilhan P; Neveu I
    Curr Med Chem; 2012; 19(35):6018-35. PubMed ID: 22963567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural stem cell-based treatment for neurodegenerative diseases.
    Kim SU; Lee HJ; Kim YB
    Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell transplantation for Huntington's diseases.
    Choi KA; Choi Y; Hong S
    Methods; 2018 Jan; 133():104-112. PubMed ID: 28867501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease.
    Venkatesh K; Sen D
    Curr Stem Cell Res Ther; 2017; 12(4):326-347. PubMed ID: 27842480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a place for human fetal-derived stem cells for cell replacement therapy in Huntington's disease?
    Precious SV; Zietlow R; Dunnett SB; Kelly CM; Rosser AE
    Neurochem Int; 2017 Jun; 106():114-121. PubMed ID: 28137534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stem cell therapy for neurodegenerative disorders].
    Meyer M; Jensen P; Rasmussen JZ
    Ugeskr Laeger; 2010 Sep; 172(38):2604-7. PubMed ID: 20920404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro generation of three-dimensional substrate-adherent embryonic stem cell-derived neural aggregates for application in animal models of neurological disorders.
    Hargus G; Cui YF; Dihné M; Bernreuther C; Schachner M
    Curr Protoc Stem Cell Biol; 2012 May; Chapter 2():Unit 2D.11. PubMed ID: 22605646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced neural stem cells as a means of treatment in Huntington's disease.
    Choi KA; Hong S
    Expert Opin Biol Ther; 2017 Nov; 17(11):1333-1343. PubMed ID: 28792249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.
    Pan-Montojo F; Funk RH
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases.
    Sadan O; Shemesh N; Cohen Y; Melamed E; Offen D
    Isr Med Assoc J; 2009 Apr; 11(4):201-4. PubMed ID: 19603590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.
    Cisbani G; Maxan A; Kordower JH; Planel E; Freeman TB; Cicchetti F
    Brain; 2017 Nov; 140(11):2982-2992. PubMed ID: 29069396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of alternate sources of cells for neural grafting in Parkinson's and Huntington's disease.
    Drouin-Ouellet J
    Neurodegener Dis Manag; 2014; 4(4):297-307. PubMed ID: 25313986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.
    Taylor H; Minger SL
    Curr Opin Biotechnol; 2005 Oct; 16(5):487-92. PubMed ID: 16143504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translation of stem cell therapy for neurological diseases.
    Schwarz SC; Schwarz J
    Transl Res; 2010 Sep; 156(3):155-60. PubMed ID: 20801412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards stem cell based therapies for Parkinson's disease.
    Parmar M
    Development; 2018 Jan; 145(1):. PubMed ID: 29311261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
    Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
    Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural stem cells for CNS transplantation.
    Baetge EE
    Ann N Y Acad Sci; 1993 Sep; 695():285-91. PubMed ID: 8239297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplants of adult mesenchymal and neural stem cells provide neuroprotection and behavioral sparing in a transgenic rat model of Huntington's disease.
    Rossignol J; Fink K; Davis K; Clerc S; Crane A; Matchynski J; Lowrance S; Bombard M; Dekorver N; Lescaudron L; Dunbar GL
    Stem Cells; 2014 Feb; 32(2):500-9. PubMed ID: 23939879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.